DCM
SWTX

Driehaus Capital Management’s SpringWorks Therapeutics SWTX Stock Holding History

Driehaus Capital Management’s Portfolio SWTX Stock Details SWTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-76,650
Closed -$2.89M – 446
2024
Q2 		$2.89M Sell
76,650
-26,993
-26% -$1.14M 0.03% 280
2024
Q1 		$5.1M Sell
103,643
-32,981
-24% -$1.52M 0.05% 280
2023
Q4 		$4.99M Sell
136,624
-397,721
-74% -$10.4M 0.06% 267
2023
Q3 		$12.4M Sell
534,345
-889
-0.2% -$24.3K 0.16% 177
2023
Q2 		$14M Sell
535,234
-23,335
-4% -$613K 0.18% 182
2023
Q1 		$14.4M Buy
558,569
+287,066
+106% +$8.39M 0.2% 163
2022
Q4 		$7.06M Sell
271,503
-2,608
-1% -$64.3K 0.11% 244
2022
Q3 		$7.82M Sell
274,111
-891,713
-76% -$25.6M 0.12% 225
2022
Q2 		$28.7M Sell
1,165,824
-675,975
-37% -$24.7M 0.46% 56
2022
Q1 		$104M Buy
1,841,799
+53,897
+3% +$3.08M 1.28% 6
2021
Q4 		$111M Buy
1,787,902
+152,755
+9% +$10.1M 1.13% 11
2021
Q3 		$104M Buy
1,635,147
+259,372
+19% +$20M 1.23% 5
2021
Q2 		$113M Buy
1,375,775
+113,700
+9% +$8.63M 1.5% 3
2021
Q1 		$92.9M Buy
1,262,075
+106,766
+9% +$8.36M 1.37% 6
2020
Q4 		$83.8M Buy
1,155,309
+180,394
+19% +$11.6M 1.35% 5
2020
Q3 		$46.5M Sell
974,915
-31,687
-3% -$1.35M 0.95% 15
2020
Q2 		$42.3M Buy
1,006,602
+256,261
+34% +$9.12M 1.03% 13
2020
Q1 		$20.3M Buy
750,341
+160,859
+27% +$5.24M 0.68% 34
2019
Q4 		$22.7M Buy
589,482
+226,222
+62% +$5.29M 0.6% 41
2019
Q3 		$7.88M Buy
+363,260
New +$8.59M 0.26% 106

Other funds holding SWTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return

Driehaus Capital Management's SWTX Position: Q3 2024 in Review

Driehaus Capital Management sold out of SpringWorks Therapeutics (SWTX) in Q3 2024, closing a stake of 76,650 shares — an estimated $2.89M sold.

Driehaus Capital Management first reported a position in SWTX in Q3 2019 and held it in 20 quarters. The position peaked at $113M in Q2 2021. 226 funds tracked by Wall St. Rank hold SWTX as of Q3 2024.

  • Driehaus Capital Management reported no remaining SpringWorks Therapeutics position as of Q3 2024 after selling out during the quarter.
  • Driehaus Capital Management sold 76,650 SpringWorks Therapeutics shares in Q3 2024, an estimated $2.89M.
  • Driehaus Capital Management first reported a position in SpringWorks Therapeutics in Q3 2019 and held it in 20 quarters.
  • Driehaus Capital Management's SpringWorks Therapeutics position peaked at $113M in Q2 2021.
  • 226 funds tracked by Wall St. Rank held SpringWorks Therapeutics as of Q3 2024.

Based on Driehaus Capital Management's 13F filing for Q3 2024, filed 14 Nov 2024.